Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Small molecule inhibitors in pancreatic cancer
Ju‐Feng Sun, Cecilia C. Russell, Christopher J. Scarlett, et al.
RSC Medicinal Chemistry (2020) Vol. 11, Iss. 2, pp. 164-183
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine
Wanyan Wang, Jiayan Cui, Hui Ma, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 115
New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types
Silpa Gampala, Hye‐ran Moon, Randall Wireman, et al.
Pharmacological Research (2024) Vol. 201, pp. 107092-107092
Open Access | Times Cited: 11
Conquering chemoresistance in pancreatic cancer: Exploring novel drug therapies and delivery approaches amidst desmoplasia and hypoxia
Pavan Kumar Chintamaneni, Sai Kiran S. S. Pindiprolu, Swati Swagatika Swain, et al.
Cancer Letters (2024) Vol. 588, pp. 216782-216782
Open Access | Times Cited: 10
C-Reactive Protein Signaling Pathways in Tumor Progression
Eun‐Sook Kim, Sun Young Kim, Aree Moon
Biomolecules & Therapeutics (2023) Vol. 31, Iss. 5, pp. 473-483
Open Access | Times Cited: 22
Identification of m6A/m5C/m1A-associated LncRNAs for prognostic assessment and immunotherapy in pancreatic cancer
Yuquan Huang, Wu Zhang, Qingxia Li, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 20
Reshaping the Pancreatic Cancer Microenvironment at Different Stages with Chemotherapy
Maozhen Peng, Ying Ying, Zheng Zhang, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2448-2448
Open Access | Times Cited: 12
Predictive value of the nutritional risk index for postoperative complications in individuals with pancreatic cancer undergoing pancreaticoduodenectomy
W. Ye, Jin Wang, Jie Zheng, et al.
Geriatric Nursing (2025) Vol. 61, pp. 605-612
Closed Access
Interaction of Avapritinib with Congo Red in Pancreatic Cancer Cells: Molecular Modeling and Biophysical Studies
Małgorzata Lasota, Daniel Jankowski, Anna Wiśniewska, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1980-1980
Open Access
Gene silencing delivery systems for the treatment of pancreatic cancer: Where and what to target next?
David Větvička, Ladislav Sivák, Chinmay M. Jogdeo, et al.
Journal of Controlled Release (2021) Vol. 331, pp. 246-259
Closed Access | Times Cited: 25
Carrier-free nanoplatforms from natural plants for enhanced bioactivity
Zhongrui Li, Xiao Xu, Yun Wang, et al.
Journal of Advanced Research (2022) Vol. 50, pp. 159-176
Open Access | Times Cited: 16
Pancreatic Cancer Health Disparity: Pharmacologic Anthropology
Nathan R. Wall, Ryan N. Fuller, Ann Morcos, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5070-5070
Open Access | Times Cited: 7
Pancreatic Cancer: Nucleic Acid Drug Discovery and Targeted Therapy
Hong Dai, Razack Abdullah, Xiaoqiu Wu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 12
Biological activity and computational analysis of novel acrylonitrile derived benzazoles as potent antiproliferative agents for pancreatic adenocarcinoma with antioxidative properties
Anja Beč, Leentje Persoons, Dirk Daelemans, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107326-107326
Closed Access | Times Cited: 2
Small molecular inhibitors: Therapeutic strategies for pancreatic cancer
Yuvasri Golivi, Seema Kumari, Batoul Farran, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104053-104053
Closed Access | Times Cited: 2
Identification of Biomarkers Associated with Oxidative Stress and Immune Cells in Acute Pancreatitis
Yuan Xu, Jie Song, Jie Gao, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 4077-4091
Open Access | Times Cited: 2
Discovery, lead identification and exploration of potential oxadiazole derivatives in targeting STAT3 as anti-cancer agents
Vivek Panwar, Sounok Sengupta, Saroj Kumar, et al.
In Silico Pharmacology (2024) Vol. 12, Iss. 2
Closed Access | Times Cited: 2
Identification and Validation of Potentially Clinically Relevant CpG Regions within the Class 2 Tumor Suppressor Gene SFRP1 in Pancreatic Cancer
Maximilian Hauschulz, Sophia Villwock, Jennifer Kosinski, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 683-683
Open Access | Times Cited: 6
Poly(anhydride-ester) gemcitabine: Synthesis and particle engineering of a high payload hydrolysable polymeric drug for cancer therapy
Rodrigo S. Heyder, Fatemah S. Sunbul, Rashed M. Almuqbil, et al.
Journal of Controlled Release (2020) Vol. 330, pp. 1178-1190
Open Access | Times Cited: 14
Overcoming the Tumor Microenvironmental Barriers of Pancreatic Ductal Adenocarcinomas for Achieving Better Treatment Outcomes
Rami M. Alzhrani, Hashem O. Alsaab, Kushal Vanamala, et al.
Advanced Therapeutics (2021) Vol. 4, Iss. 6
Open Access | Times Cited: 11
Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer
Masahiro Uehara, Takahiro Domoto, Satoshi Takenaka, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 1
A 15-Inflammation-Related Gene Signature Predicts the Prognosis of Patients With Pancreatic Ductal Adenocarcinoma
Xiaofeng Sun, Hao Song, Xiaoran Sun, et al.
Cancer Investigation (2024) Vol. 42, Iss. 3, pp. 226-242
Open Access | Times Cited: 1
Evaluation of Helium Ion Radiotherapy in Combination with Gemcitabine in Pancreatic Cancer In Vitro
Bahar Cepni, Thomas Tessonnier, Ivana Đokić, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1497-1497
Open Access | Times Cited: 1
Comparative Analysis of Leptin and Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Plasma Expression in Pancreatic Cancer and Chronic Pancreatitis Patients
Gina Gheorghe, Carmen C. Diaconu, Cristina Mambet, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e37410-e37410
Open Access | Times Cited: 1
Crosstalk between miRNAs and signaling pathways involved in pancreatic cancer and pancreatic ductal adenocarcinoma
Ziba Lotfi, Shiva Najjary, Fariba Lotfi, et al.
European Journal of Pharmacology (2021) Vol. 901, pp. 174006-174006
Closed Access | Times Cited: 10
A small molecule inhibits pancreatic cancer stem cells
Jayanta Das, Madhumita Das, Mayur Doke, et al.
International Journal of experimental research and review (2021) Vol. 26, pp. 1-15
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top